Prevention of postmenopausal bone loss using tibolone or conventional peroral or transdermal hormone replacement therapy with 17β-estradiol and dydrogesterone

Journal of Bone and Mineral Research

Volumn 12, Issue 5, 1997, Pages 806-812

  Lippuner, Kurt ^a   Haenggi, Willy ^b   Birkhaeuser, Martin H ^b   Casez, Jean Paul ^a   Jaeger, Philippe ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

DYDROGESTERONE; ESTRADIOL; GESTAGEN; TIBOLONE;

ABSORPTIOMETRY; ADULT; ARTICLE; BONE DENSITY; BONE MASS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DENSITOMETRY; DISEASE CONTROL; DOSE RESPONSE; ESTRADIOL BLOOD LEVEL; FEMALE; HORMONE SUBSTITUTION; HUMAN; HYSTERECTOMY; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; OSTEOPOROSIS; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIAL; TRANSDERMAL DRUG ADMINISTRATION; TREATMENT PLANNING;

EID: 0031006180     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.1997.12.5.806     Document Type: Article

References (33)

1. Recker RR, Saville PD, Heaney RP 1977 The effect of estrogen and calcium carbonate on bone loss in postmenopausal women. Ann Intern Med 87:649-655.
2. Christiansen C, Christensen MS, McNair P, Hagen C, Stocklund KE, Transbol I 1980 Prevention of early postmenopausal bone loss: Controlled 2-year study in 315 normal females. Eur J Clin Invest 10:273-279.
3. Genant HK, Cann CE, Ettinger B, Gordan GS 1982 Quantitative computed tomography of vertebral spongiosa: A sensitive method for detecting early bone loss after oophorectomy. Ann Intern Med 97:699-705.
4. Nachtigall LE, Nachtigall RH, Nachtigall RD, Beckman EM 1979 Estrogen replacement therapy: A 10 year prospective study in the relationship to osteoporosis. Obstet Gynecol 53:277-281.
5. Stevenson JC, Cust MP, Gangar KF, Hillard TC, Lees B, Whitehead MI 1990 Effects of transdermal versus oral hormone replacement therapy on bone density in spine and proximal femur in postmenopausal women. Lancet 335:265-269.
6. Felson DT, Zhang Y, Hannan MT, Kiel DP, Wilson PWF, Anderson JJ 1993 The effect of postmenopausal estrogen therapy on bone density in elderly women. N Engl J Med 329:1141-1146.
7. Spector TD 1989 Use of estrogen replacement therapy in high risk groups in the United Kingdom. Br Med J 299:1434-1435.
8. Ryan PJ, Harrison R, Blake GM, Fogelman I 1992 Compliance with hormone replacement therapy (HRT) after screening for post menopausal osteoporosis. Br J Obstet Gynaecol 99:325-328.
9. Cano A 1995 Compliance to hormone replacement therapy in menopausal women controlled in a third level academic centre. Maturitas 20:91-99.
10. Grady D, Gebretsadik T, Kerlikowske K, Ernster V, Petitti D 1995 Hormone replacement therapy and endometrial cancer risk: A meta-analysis. Obstet Gynecol 85:304-313.
11. The Writing group for the PEPI Trial 1995 Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. JAMA 273:199-208.
12. Gambrell RD 1986 Prevention of endometrial cancer with progestogens. Maturitas 8:159-168.
13. Vies van der J 1987 Pharmacological studies with OD14. Maturitas Suppl 1:15-24.
14. Tax L, Goorissen EM, Kicovic PM 1987 Clinical profile of Org OD 14. Maturitas Suppl 1:3-13.
15. Lindsay R, Hart DM, Kraszewski A 1980 Prospective double blind trial of synthetic steroid (Org OD 14) for preventing postmenopausal osteoporosis. Br Med J 1:1207-1209.
16. Rymer J, Chapman MG, Fogelman I 1994 Effect of tibolone on postmenopausal bone loss. Osteoporos Int 4:314-319.
17. Berning B, Kuijk CV, Kuiper JW, Coelingh Bennink HJT, Kicovic PM and Fauser BCJM 1996 Effects of two doses of tibolone on trabecular and cortical bone loss in early post- menopausal women: A two-year randomized, placebo-controlled study. Bone 19:395-399.
18. Kupperman HS, Blatt MHG, Wiesbaden H, Filler W 1953 Comparative clinical evaluation of estrogenic preparations by the menopausal and amenorrheal indices. J Clin Endocrinol Metab 13:88-93.
19. Ryde SJS, Bowen-Simpkins K, Bowen-Simpkins P, Evans WD, Morgan WD, Compston JE 1994 The effect of oestradiol implants on regional and total bone mass: A three-year longitudinal study. Clin Endocrinol 40:33-38.
20. Aloia JF, Vaswani A, Yeh JK, Ross PL, Plaster E, Dilmanian A 1994 Calcium supplementation with and without hormone replacement therapy to prevent postmenopausal bone loss. Ann Intern Med 120:97-103.
21. Gallagher JC, Kable WT, Goldgar D 1991 Effect of progestin therapy on cortical and trabecular bone: Comparison with estrogen. Am J Med 90:171-178.
22. Rozenberg S, Vandromme J, Kroll M, Pastijn A, Degueldre M 1994 Osteoporosis prevention with sex hormone replacement therapy. Int J Fertil 39:262-271.
23. Geusens P, Dequeker J, Gielen J, Schot LPC 1991 Non-linear increase in vertebral density induced by a synthetic steroid (Org OD 14) in women with established osteoporosis. Maturitas 13:155-162.
24. De Visser J, Coert A, Feenstra H, Van der Vies J 1984 Endocrinological studies with (7-α, 17-α)-17-hydroxy-7-methyl-19-norpregn-5(10)-en-20-yn-3-one (Org OD 14). Arznei Forsch 34:1010-1017.
25. Longcope C, Baker RS, Hui SL, Johnston CC 1984 Androgen and estrogen dynamics in women with vertebral crush fractures. Maturitas 6:309-318.
26. Davidson BJ, Ross RK, Paganini-Hill A, Hammond GD, Siiteri PK, Judd HL 1982 Total and free estrogens and androgens in postmenopausal women with hip fractures. J Clin Endocrinol Metab 54:115-120.
27. Watts NB, Notelovitz M, Timmons MC, Addison WA, Wiita B, Downey IJ 1995 Comparison of oral estrogens and estrogens plus androgen on bone mineral density, menopausal symptoms, and lipid-lipoprotein profiles in surgical menopause. Obstet Gynecol 85:529-537.
28. Erdtsieck RJ, Pols HAP, van Kuijk C et al. 1994 Course of bone mass during and after hormone replacement therapy with and without addition of nandrolone decanoate. J Bone Miner Res 9:227-283.
29. Taylor WN, Alanis C 1992 Triple sex steroid replacement therapy for osteoporosis after surgical menopause. J Neurol Orthop Med Surg 13:16-19.
30. Chesnut CH III, Ivey JL, Gruber HE, et al 1983 Stanzolol in postmenopausal osteoporosis: Therapeutic efficacy and possible mechanisms of action. Metabolism 32:571-580.
31. Lindsay R, Hart DM, Purdie D, Ferguson MM, Clark AS, Kraszewski A 1978 Comparative effects of estrogen and a progestogen on bone loss in postmenopausal women. Clin Sci Mol Med 54:193-195.
32. Marr W, Elder MG, Lim L 1980 The effects of estrogens and progesterone on estrogen receptors in the rat liver. Biochem J 19:563.
33. Reed MJ, Ross MS, Lai LC et al. 1990 In vivo conversion of norethisterone to ethinyl estradiol in perimenopausal women. J Steroid Biochem Mol Biol 37:301.